Side-by-side comparison of AI visibility scores, market position, and capabilities
Binx Health develops FDA-cleared point-of-care molecular diagnostic platforms delivering chlamydia and gonorrhea results in 30 minutes at doctors offices; raised $280M total including $65M Series F in 2024; backed by EQT and OrbiMed.
Binx Health is a molecular diagnostics company founded in 2012 and headquartered in Boston, Massachusetts. The company develops point-of-care (POC) molecular testing platforms designed to bring lab-quality STI diagnostics to clinical settings outside traditional centralized laboratories — including physicians'' offices, urgent care clinics, pharmacies, and hospital emergency departments. Binx''s flagship platform, the binx io system, is FDA-cleared and CLIA-waived, enabling non-laboratory staff to perform certified molecular tests for chlamydia and gonorrhea with results delivered in approximately 30 minutes. CLIA-waiver status is critical because it allows the system to be operated in any point-of-care setting without requiring a laboratory director.
Doximity (NYSE: DOCS), professional network for US physicians with 2M+ verified clinicians; telehealth, medical news, and career tools monetized via pharmaceutical digital marketing.
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinicians on the platform — representing the majority of practicing US physicians — Doximity has established itself as the dominant professional network for doctors, providing identity-verified peer connections, specialty-specific news feeds, medical journal access, and career management tools including a physician job board and CV builder. The verification layer distinguishes Doximity from general professional networks and makes it the standard reference for confirming physician credentials and contact information across the healthcare industry.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.